Middle-up quantification of therapeutic monoclonal antibodies in human plasma with two dimensional liquid chromatography high resolution mass spectrometry: Adalimumab as a proof of principle
Mohsin El Amrani, Kim C.M. van der Elst, Alwin D.R. Huitema, Matthijs van Luin
Research output: Contribution to journal › Article › peer-review
6Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Middle-up quantification of therapeutic monoclonal antibodies in human plasma with two dimensional liquid chromatography high resolution mass spectrometry: Adalimumab as a proof of principle'. Together they form a unique fingerprint.